# IRBESARTAN
> **ANDA077205** · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL MOLECULAR · Approved 2012-11-14
## Drug
- **FDA Application Number:** ANDA077205
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IRBESARTAN
- **Generic name:** IRBESARTAN
- **Active ingredients:** IRBESARTAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CHARTWELL MOLECULAR
- **Manufacturer:** Chartwell RX, LLC
- **First approval:** 2012-11-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077205)
---
*MORVS · CC0 1.0*